Skip Page Header

Home > Items where Subject is "E Concepts in biomedical areas > Pharmacology and toxicology > Potency / strength / purity / adulterant"

Up a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 53.

Article

Freeman, Tom P and Craft, Sam and Wilson, Jack and Stylianou, Stephan and ElSohly, Mahmoud and Di Forti, Marta and Lynskey, Michael T (2021) Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction , 116 , (5) , pp. 1000-1010.

McCartney, Danielle and Arkell, Thomas R and Irwin, Christopher and McGregor, Iain S (2021) Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neuroscience and Biobehavioral Reviews , 126 , pp. 175-193.

Gray, Paul and Ralphs, Rob and Williams, Lisa (2021) The use of synthetic cannabinoid receptor agonists (SCRAs) within the homeless population: motivations, harms and the implications for developing an appropriate response. Addiction Research & Theory , 29 , (1) , pp. 1-10.

Sorkhou, Maryam and Bedder, Rachel H and George, Tony P (2021) The behavioral sequelae of cannabis use in healthy people: a systematic review. Frontiers in Psychiatry , 12 , p. 630247.

Leung, Janni and Stjepanović, Daniel and Dawson, Danielle and Hall, Wayne D (2021) Do cannabis users reduce their THC dosages when using more potent cannabis products? A review. Frontiers in Psychiatry , 12 , p. 630602.

Silver, Lynn D and Naprawa, Amanda Z and Padon, Alisa A (2020) Assessment of incorporation of lessons from tobacco control in city and county laws regulating legal marijuana in California. JAMA Network Open , 3 , (6 e208393) , e208393.

Maloney-Hall, Bridget and Wallingford, Sarah C and Konefal, Sarah and Young, Matthew M (2020) Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006-2015. Health Promotion and Chronic Disease Prevention in Canada , 40 , (5-6) , pp. 176-183.

Hines, Lindsey A and Freeman, Tom P and Gage, Suzanne H and Zammit, Stanley and Hickman, Matthew and Cannon, Mary and Munafo, Marcus and MacLeod, John and Heron, Jon (2020) Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry , 77 , (10) , pp. 1044-1051.

Alam, Ryan M and Keating, John J (2020) Adding more "spice" to the pot: a review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists. Drug Testing and Analysis , 12 , (3) , pp. 297-315.

Rehm, Jürgen and Crépault, Jean-François and Hasan, Omer S M and Lachenmeier, Dirk W and Room, Robin and Sornpaisarn, Bundit (2019) Regulatory policies for alcohol, other psychoactive substances and addictive behaviours: the role of level of use and potency. a systematic review. International Journal of Environmental Research and Public Health , 16 , (19) , p. 3749.

Di Forti, Marta and Quattrone, Diego and Freeman, Tom P and Tripoli, Giada and Gayer-Anderson, Charlotte and Quigley, Harriet and Rodriguez, Victoria and Jongsma, Hannah E and Ferraro, Laura and La Cascia, Caterina and La Barbera, Daniele and Tarricone, Ilaria and Berardi, Domenico and Szöke, Andrei and Arango, Celso and Tortelli, Andrea and Velthorst, Eva and Bernardo, Miguel and Del-Ben, Cristina Marta and Rossi Menezes, Paulo and Selten, Jean Paul and Jones, Peter B and Kirkbride, James B and Rutten, Bart PF and et al, . (2019) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet. Psychiatry , 6 , (5) .

Freeman, Tom P and Groshkova, Teodora and Cunningham, Andrew and Sedefov, Roumen and Griffiths, Paul and Lynskey, Michael T (2019) Increasing potency and price of cannabis in Europe, 2006‐2016. Addiction , 114 , (6) .

Vasiljevic, Milica and Coulter, Lucia and Petticrew, Mark and Marteau, Theresa M (2018) Marketing messages accompanying online selling of low/er and regular strength wine and beer products in the UK: a content analysis. BMC Public Health , 18 , (147) .

Montanari, Linda and Guarita, Bruno and Mounteney, Jane and Zipfel, Nina and Simon, Roland (2017) Cannabis use among people entering drug treatment in Europe: a growing phenomenon? European Addiction Research , 23 , (3) , pp. 113-121.

Sumpter, Colin and McGill, Elizabeth and Dickie, Esther and Champo, Enes and Romeri, Ester and Egan, Matt (2016) Reducing the Strength: a mixed methods evaluation of alcohol retailers' willingness to voluntarily reduce the availability of low cost, high strength beers and ciders in two UK local authorities. BMC Public Health , 16 , (1) , p. 448.

Mounteney, Jane and Giraudon, Isabelle and Denissov, Gleb and Griffiths, Paul (2015) Fentanyls: are we missing the signs? Highly potent and on the rise in Europe. International Journal of Drug Policy , 26 , (7) , pp. 626-631.

Afridi, Hassan Imran and Talpur, Farah Naz and Kazi, Tasneem Gul and Brabazon, Dermot (2015) Effect of trace and toxic elements of different brands of cigarettes on the essential elemental status of Irish referent and diabetic mellitus consumers. Biological Trace Element Research , 167 , (2) , pp. 209-224.

Afridi, Hassan Imran and Kazi, Tasneem Gul and Talpur, Farah Naz and Brabazon, Dermot and Naher, Sumsun (2013) Estimation of toxic elements in the samples of different cigarettes and their impact on human health of Irish hypertensive consumers. Clinica Chimica Acta , 426C , pp. 51-57.

Dowling, Geraldine and Regan, L (2011) A new mixed mode solid phase extraction strategy for opioids, cocaines, amphetamines and adulterants in human blood with hybrid liquid chromatography tandem mass spectrometry detection. Journal of Pharmaceutical and Biomedical Analysis , 54 , (5) , pp. 1136-1145.

Davies, Ronald B (2010) Mandatory minimum sentencing, drug purity and overdose rates. Economic and Social Review , 41 , (4) , pp. 429-457.

Long, Jean (2010) Adulterants, bulking agents and contaminants in illicit drugs. Drugnet Ireland , Issue 35, Autumn 2010 , pp. 18-20.

News

[Irish Examiner] , Fagan, Maresa Higher-potency cannabis poses 'gravest threat' to young people's mental health. (04 May 2021)

[Irish Examiner] , O'Keeffe, Cormac Sharp rise in purity of cocaine street deals. (24 Mar 2021)

[Irish Times] , Lally, Conor Garda begin seizing highly-potent cannabis. (31 Dec 2020)

Hot Press News Desk. [Hot Press] Global Drug Survey predicts that "following lockdown, many regions will be flooded by high purity drugs". (04 Jun 2020)

[Irish Examiner] , O'Keeffe, Cormac International Narcotics Control Board identify a ‘surge’ in high-purity cocaine in Europe. (06 Mar 2020)

[Irish Examiner] , O'Keeffe, Cormac Electric Picnic festival goers warned of high strength drugs. (29 Aug 2019)

[Independent.ie] , Kelly, Aoife 'Bad batch is a red herring' - Irish doctor dispels drug myths and warns festival-goers about high potency MDMA. (29 Aug 2019)

[Irish Times] , Gallagher, Conor Cannabis: More people seeking treatment as strength doubles. (12 Jan 2019)

[The Sunday Times] , O'Neill, Kate Drug strength warning. (21 Oct 2018)

[Irish Examiner] , O'Keeffe, Cormac Overdose fears due to variation in cocaine purity. (28 Oct 2016)

[thejournal.ie] People are risking their lives making super-strength cannabis in the UK. (05 Aug 2016)

[Irish Examiner] , O'Keeffe, Cormac DRUGS CRISIS: rising drug potency poses greater danger. (05 Jun 2015)

Report

European Monitoring Centre for Drugs and Drug Addiction. (2021) Methamphetamine developments in South Asia: the situation in Iran and the implications for the EU and its neighbours, EU4MD special report. Luxembourg: Publications Office of the European Union.

Aldridge, Judith and Garius, Laura and Spicer, Jack and Harris, Magdalena and Moore, Karenza and Eastwood, Niamh (2021) Drugs in the time of COVID: the UK drug market response to lockdown restrictions. Interim findings. London: Release.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}amino)-3,3-dimethylbutanoate (4F-MDMB-BICA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Corfe, Scott and Hyde, Richard and Shepherd, Jake (2020) Alcohol-free and low-strength drinks: understanding their role in reducing alcohol-related harms. London: The Social Market Foundation.

Canadian Centre on Substance Use and Addiction. (2020) Clearing the smoke on cannabis: edible cannabis products, cannabis extracts and cannabis topicals. Canadian Centre on Substance Use and Addiction.

Hughes, Caitlin and Hulme, Shann and Ritter, Alison (2020) The relationship between drug price and purity and population level harm. Canberra: Australian Institute of Criminology.

Payer, Doris E and Young, Matthew M and Maloney-Hall, Bridget and Mill, C and LeClerc, Pascale and Buxton, Jane A (2020) Adulterants, contaminants and co-occurring substances in drugs on the illegal market in Canada: an analysis of data from drug seizures, drug checking and urine toxicology. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.

North, Paul (2017) Street lottery: cannabis potency and mental health. London: Volteface.

Manchester Health & Care Commissioning. (2017) Spice. Synthetic cannabinoids (SCRAs). Manchester Health & Care Commissioning.

O’Neill, Geraldine and Clinton, Darrell and Lynch, Brendan (2016) Purity of illicit drugs submitted to Forensic Science Ireland 2015. Dublin: Forensic Science Ireland.

Jones, Lisa and Bellis, Mark A (2012) 'Can promotion of lower strength alcohol products help reduce alcohol consumption? A rapid literature review. Liverpool: Liverpool John Moores University. North West Public Health Observatory.

Center for Substance Abuse Treatment. (2012) Clinical drug testing in primary care. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Forensic Science Laboratory. Arnold, Colette (2011) The potency of THC in Cannabis products. Dublin: National Advisory Committee on Drugs.

Cole, Claire and Jones, Lisa and McVeigh, Jim and Kicman, Andrew and Syed, Qutub and Bellis, Mark A (2010) Cut: a guide to adulterants, bulking agents and other contaminants found in illegal drugs. Liverpool: Faculty of Health and Applied Social Sciences, Liverpool John Moores University.

Hope, Ann (2009) A standard drink in Ireland: what strength? Dublin: Health Service Executive Alcohol Implementation Group.

King, Leslie A (2004) An overview of cannabis potency in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Dataset

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA statistical bulletin 2020.

FactSheet

National Institute on Drug Abuse. (2020) DrugFacts: Marijuana concentrates. Bethesda, MD: National Institute on Drug Abuse.

Drugs.ie. (2017) The strength of your cannabinoid may be higher than you think. Synthetic Cannabinoids (‘Spice’). Dublin: drugs.ie.

This list was generated on Sat May 8 04:02:15 2021 IST.